A randomized controlled trial for Shugan Tiaoshen integrated program of acupuncture and moxibustion in the treatment of moderate depressive disorder

Guangdong Hospital of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. The results were in accordance with the diagnostic criteria of traditional Chinese and Western medicine;
•2. Age 18-65 years old, junior high school or above;
•3. The 17 item Hamilton Depression Scale (HAMD-17) scores were more than 17 and less than 24;
•4. They signed informed consent and volunteered to participate in this study.
•Only those who meet the above 4 items can be included in the study.

•1. Those with suicidal tendency;
•2. Previous diagnosis of mental retardation, schizophrenia, bipolar disorder, substance abuse (such as alcohol dependence) or other mental disorders;
•3. History of epilepsy, family history of strong positive epilepsy, history of brain organic diseases and severe somatic diseases;
•4. Those who are taking antidepressants within 6 weeks (including 6 weeks);
•5. Pregnancy, pregnancy preparation or lactation;
•6. Patients with skin lesions or skin diseases, severe diabetes mellitus, tumor and important organ dysfunction, or severe internal diseases such as liver, kidney, cardiovascular, endocrine, respiratory and hematopoietic systems;
•Those who met any of the above criteria were excluded from the study.

发起方

Guangdong Hospital of traditional Chinese Medicine